India allows Serum Institute to enrol 7-11 year olds in Novavax COVID-19 vaccine trial

BENGALURU (Reuters) -India’s drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of U.S. drugmaker Novavax’s COVID-19 vaccine, as the country prepares to protect children from the novel coronavirus. Read full story

Source : https://www.thestar.com.my/news/world/2021/09/28/india-allows-serum-institute-to-enrol-7-11-year-olds-in-novavax-covid-19-vaccine-trial